Medivaxia Pharma (Top Monopoly Pharma PCD Franchise Company in Himachal Pradesh)

 

Medivaxia Pharma (Top Monopoly Pharma PCD Franchise Company in Himachal Pradesh)

Medivaxia Pharma is Chandigarh based pharmaceutical company which deals in Pharma manufacturing and PCD Franchise Business. It is one of the rapidly growing pharmaceutical formulations manufacturing, marketing, and export oriented company. Manufacturing and marketing of quality pharmaceutical formulations affordable to the Indian masses and having global quality is our motto it. So Medivaxia Pharma is top PCD Pharma Franchise Company in Himachal Pradesh.

The company is offering PCD Franchise in Himachal Pradesh and Third Party Manufacturing in Himachal Pradesh .

Tag : be pharma company, pharma marketing companies in india, top pharma companies in mumbai, pd pharma, largest pharmaceutical companies, top pharma industries in india, top ten pharma company in india 2016, top 5 medicine company in india, franchise pharma marketing, new pharma companies in india,

Medivaxia Pharma is keen for in Himachal Pradesh for the following regions :

Monopoly Franchise of Medivaxia Pharma in Districts

Chamba , Mandi , Kangra , Kullu , Solan , Shimla , Una , Bilaspur , Hamirpur , Sirmaur ,

Monopoly Franchise of Medivaxia Pharma in Cities

Nurpur , Rampur , Rawalsar , Una , Nalagarh , Jawalamukhi , Shimla , Sarkaghat , Santokhgarh , Chaupal , Jogindarnagar , Gagret , Sabathu , Baddi , Yol , Mant Khas , Rohru , Seoni , Jutogh , Dalhousie , Daulatpur , Kullu , Naina Devi , Bilaspur , Tira Sujanpur , Narkanda , Kasauli , Bhota , Dagshai , Dera Gopipur , Manali , Jubbal , Nahan , Paonta Sahib , Sundarnagar , Chamba , Ghumarwin , Bakloh , Talai , Theog , Palampur , Kotkhai , Rajgarh , Dharmsala , Bhuntar , Mandi , Chuari Khas , Arki , Solan , Hamirpur , Nagrota Bagwan , Kangra , Parwanoo , Banjar , Nadaun , Mehatpur Basdehra ,



Address : 513-C,5th Floor, Elante Office, Industrial & Business Park, Phase-I, Chandigarh - 160002
Website : https://www.medivaxiapharma.in

Comments